|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.990 USD | -1.97% |
|
-5.38% | -17.17% |
| 07-07 | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
| 06-29 | Altimmune, Inc.(NasdaqGM:ALT) dropped from Russell Small Cap Comp Growth Benchmark | CI |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | -4.53x | - | 0.14x | 51246.99x | -1.65x | -1.74x | - | 593M | |
| 20.57x | 3.94x | -2.21x | 6.33x | 13.8x | 16.03x | 1.56% | 54.88B | |
| 32.72x | 6.04x | 0.8x | 8.29x | 25.68x | 26.28x | 0.06% | 54.63B | |
| -44.31x | 58.73x | 0.75x | 14.51x | -42.32x | -46.19x | -.--% | 25.06B | |
| -18.2x | 1.12x | 2.82x | 4.33x | -7.58x | -6.22x | -.--% | 23.14B | |
| 25x | 2.44x | 1.89x | 4.9x | 12.9x | 15.47x | -.--% | 19.87B | |
| 24.48x | 2.78x | -1.14x | 4.79x | 15.58x | 17.57x | -.--% | 17.55B | |
| 49.34x | 12.65x | 0.44x | 20.07x | 51.69x | 47.42x | 0.07% | 16.5B | |
| -539.24x | 22.13x | 10.94x | 37.99x | -4235.53x | -415.82x | -.--% | 15.75B | |
| 17.75x | 5.04x | 1.23x | 5.16x | 12.01x | 13.24x | -.--% | 14.2B | |
| -75.86x | 27.53x | 1.69x | 7.92x | -71.02x | -56.89x | -.--% | 12.37B | |
| -13.41x | 157.83x | 0.65x | 3496.65x | -16.27x | -13.27x | -.--% | 11.84B | |
| -13.25x | -89.92x | 6.52x | 98.41x | -15.05x | -14.64x | -.--% | 11.52B | |
| 3299.58x | 8.05x | -32.33x | 14.16x | 86.43x | 296.49x | -.--% | 11.43B | |
| -24.11x | 24.85x | -0x | 22.23x | -28.27x | -22.87x | -.--% | 10.76B | |
| -21.6x | 8.28x | 11x | 804.19x | -18.87x | -18.78x | -.--% | 9.83B | |
| 12.43x | 5.95x | 0.04x | 8.41x | 13.61x | 14.37x | -.--% | 9.22B | |
| -17.71x | 8.8x | 3.79x | 113.55x | -15.88x | -14.43x | - | 8.81B | |
| -9.67x | - | -0.08x | - | - | - | - | 8.61B | |
| -31.8x | 8.74x | -0.58x | - | -29.38x | -28.42x | -.--% | 8.59B | |
| Average | 133.41x | 15.28x | 0.32x | 3,106.61x | -223.69x | -10.13x | 0.1% | 17.26B | |
| Weighted average by Cap. | 88.27x | 13.67x | 0.27x | 258.73x | -193.83x | -6.72x | 0.27% |
- Stock Market
- Stocks
- ALT Stock
- Sector Altimmune, Inc.
- Sector valuations
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition